STING1 and amyotrophic lateral sclerosis: Nevertheless, C9-ALS patients were shown to have an increased type I interferon signature and a treatment with STING inhibitor suppressed this interferon response which could partially explain the involvement of STING as an underlying mechanism of the enhanced inflammatory profile in C9-ALS patients [222].